Activating STAT mutations do also exist outside of the SH2 domain in hematological cancers [60,63,64,65] and DNA binding domain mutations of STAT6 are associated with B-cell malignancies [66,67,68,69]. This evidence concerns the gene SOAT1 and hematopoietic and lymphoid cell neoplasm.